Multidrug-resistant Tuberculosis and its Implication with COVID-19

J Arya, S Dahiya, AK Chhillar - Coronaviruses, 2023 - ingentaconnect.com
Mycobacterium tuberculosis is the leading cause of death due to pulmonary diseases and
has developed resistance to various antibiotics over time making it extremely difficult to treat …

[HTML][HTML] Кортикостероиды в лечении пациентов с поражением легких, обусловленным инфекцией SARS-CoV-2

ВТ Ивашкин, ОЮ Зольникова, АА Свистунов… - Сеченовский …, 2020 - cyberleninka.ru
Цель. Изучить эффективность применения кортикостероидов в лечении пациентов с
поражением легких, обусловленным SARS-CoV-2. Материалы и методы. В …

Risk factors for mortality in patients over 65 years old hospitalized by COVID-19

FI JM, MB MDC, GA MÁ, FA MJ, A Arias… - Revista Espanola de …, 2021 - europepmc.org
Objective to identify factors associated with the death of patients aged 65 years or older
hospitalized for COVID-19. Materials and methods Retrospective cohort study. We included …

Considering heparin-related coagulation status when providing motor exercise in patients with COVID-19

M Polastri, G Corsi, L Pisani… - International Journal of …, 2020 - magonlinelibrary.com
© 2020 MA Healthcare Ltd state, in addition to the usual risk factors for venous
thromboembolism that a medical inpatient has. At present, several ongoing studies are …

[HTML][HTML] Pregnancy, peripartum, and COVID-19: An updated literature review

F Jahanshahlou, A Mahmoodpoor, S Sanaie… - Electronic Journal of …, 2022 - ejgm.org
Due to the physiological changes of the pregnancy and considering the susceptibility of the
fetus, pregnant women are among the vulnerable health groups. The current COVID-19 …

Polyherbal Syrup for Coronavirus Infection: Formulation and Evaluation

KK Kotta, SK Kadiri, SA Gouru - Coronaviruses, 2024 - ingentaconnect.com
Background: SARS-CoV-2 emerged in Wuhan in December 2019, and after that, it spread
quickly around the world. The virus could spread to millions of individuals since there were …

Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID-19 Affection and Severity

AA Mohamed, S Abd-Elsalam… - … Current Drug Targets …, 2023 - ingentaconnect.com
Background & Aims: Coronavirus disease-2019 (COVID-19) is a major pandemic that
causes high morbidity and mortality rates. Aim of this study: to detect the relations between …

Risk Factors Associated with In-Hospital Mortality in Iranian Patients with COVID-19: Application of Machine Learning

S Shafiekhani, S Rafiei, S Abdollahzade… - Polish Journal of …, 2022 - sciendo.com
Results: In prediction of mortality, Ensemble demonstrated the maximum values of accuracy
(0.8071, 95% CI: 0.7787, 0.8356), F1-score (0.8121 95% CI: 0.7900, 0.8341), and AUROC …

[HTML][HTML] Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases

J Shi, W Zhang, L Sang, Z Qu, M Zhong, B Song… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Coagulation dysfunction in critically ill patients with coronavirus disease 2019 (COVID-19)
has not been well described, and the efficacy of anticoagulant therapy is unclear. In this …

[HTML][HTML] COVID-19 and diabetes cutaneous comorbidity

M Zhang, W Gao - Metabolism Open, 2020 - Elsevier
Diabetes patients have a higher risk in morbidity and mortality with COVID-19. It should be
considered as a risk factor for a rapid progression and bad prognosis of COVID-19 …